United States · FDA National Drug Code directory
Lovenox
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0075-8014_006561fa-e16d-4129-9dde-89c109b51d8f
- Product NDC
- 0075-8014
- Form
- INJECTION
- Composition / generic term
- enoxaparin sodium
- Labeler
- Sanofi-Aventis U.S. LLC
- Marketing category
- NDA
- Marketing start / end (source format)
- 19930329
- Source listing expiry
- 20271231
Source-listed ingredients
- ENOXAPARIN SODIUM — 40 mg/.4mL
These values do not establish equivalence or a dose recommendation.
Packages
- 10 CELLO PACK in 1 CARTON (0075-8014-10) / 1 SYRINGE in 1 CELLO PACK / .4 mL in 1 SYRINGE (0075-8014-01) · 0075-8014-10
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →